2024 @Philly Cell And Gene Therapy Annual Conference

We are delighted to extend to you an invitation to serve as a distinguished speaker at the upcoming 2024 Philadelphia Cell & Gene Therapy (CGT) Conference (https://atphilly.org/). This seminal event is scheduled for June 14-15, 2024, at the Sheraton Valley Forge Hotel, located at 480 N Gulph Rd, King of Prussia, PA 19406.

The close of 2023 witnessed the approval of up to 13 novel cell or gene therapies across the U.S. and Europe, marking a pivotal moment for our industry. This era is characterized by a burgeoning number of enterprises dedicated to CGT, buoyed by a robust influx of investment, setting the stage for unparalleled growth in the coming year. Our conference is designed to unify principal stakeholders from the region, harnessing their collective resources to enhance the prominence of the CGT landscape. It serves as an unparalleled forum for pioneers, industry leaders, service providers, policymakers, and investors to forge connections and foster collaborations. Historically, the event has drawn in excess of 500 participants, comprising C-level executives (14%), vice presidents (7%), directors (25%), and scientists (27%) from major pharmaceutical companies, biotech firms, and academic institutions throughout the tri-state area.

The 2024 edition of the Philadelphia CGT Conference will explore an extensive array of subjects, including Cell Therapy, Gene Therapy, RNA & Gene Editing, CMC, and Clinical Development and Regulatory frameworks. Additionally, the conference will feature seven sessions dedicated to business development, non-scientific services, real estate, and economic incentives for CGT entities within the PA/DE/NJ region.

We are proud to announce our confirmed speakers, a list that includes industry veterans such as

• Peter Marks, MD PhD, Center for Biologics Evaluation and Research (CBER) at FDA
• Jason Bock, Founder & CEO, CTMC
• Sonali Patel, Director, Regulatory Strategy, Spark Therapeutics
• Chris Daniels, Associate Director & High-Throughput Technology Development Lead, Spark Therapeutics
• Tonya Hutchison, Senior Director, Quality Control & Quality Operations, Spark Therapeutics
• Steve Huge, Director, GenScript Biotech
• Gareth Thomas, Associate Professor, Lewis Katz School of Medicine at Temple University
• More to come…

We eagerly await you joining us and hope to welcome you to an event that promises to be both enlightening and inspiring.

Warmest regards,

SAPA-GP

Host or Publisher SAPA-GP